Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-γ and tumor necrosis factor-Reference-Cited by-同舟云学术

Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-γ and tumor necrosis factor

Published:1991-01 Issue:2 Volume:140 Page:269-279
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Barth Richard J.,Mulé James J.,Asher Anthony L.,Sanda Martin G.,Rosenberg Steven A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. F4/80, a monoclonal antibody directed specifically against the mouse macrophage;Austyn;Eur. J. Immunol.,1981

2. Unique murine tumor associated antigens identified by tumor infiltrating lymphocytes;Barth;J. Immunol.,1990

3. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor infiltrating lymphocytes;Barth;J. Exp. Med.,1990

4. Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells;Evans;Transplantation,1971

5. Alloreactive murine CD8+ T cell clones secrete the TH1 pattern of cytokines;Fong;J. Immunol.,1990

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Perspectives on Nasopharyngeal Carcinoma;Advances in Experimental Medicine and Biology;2019

2. TCR Mimic Monoclonal Antibody Targets a Specific Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models;The Journal of Immunology;2010-01-11

3. High number of tumour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma;APMIS;2008-07-07

4. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo;Cytotherapy;2005

5. Optimizing T-Cell Adoptive Immunotherapy to Overcome Tumor Evasion;Cancer Immunotherapy at the Crossroads;2004